HBIO

4.71% 0.0211

Handel nachbörslich: .47 0.0005 +0.11%

Harvard Bioscience Inc (HBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1166)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HBIO Harvard Bioscience Inc	0.4695	26.29M	106.79M	-8.73M	10.81M	-0.20
ISRG Intuitive Surgical Inc	540.60	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	177.27	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	89.30	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	255.88	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	221.22	16.36B	2.90B	467.20M	306.90M	6.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2021-01-07	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2020-12-09	Eingeleitet	Northland Capital	Outperform
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2019-07-08	Herabstufung	Janney	Buy → Neutral
2018-01-24	Bestätigt	Janney	Buy
2018-01-23	Bestätigt	The Benchmark Company	Buy
2016-11-17	Eingeleitet	Singular Research	Buy
2015-07-28	Eingeleitet	The Benchmark Company	Buy

Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Vergleichen Sie HBIO mit anderen Aktien

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX

Major Improvements In Harvard Bioscience Inc (HBIO) Stock Need To Be Considered - Stocksregister

Harvard Bioscience appoints new board member as director steps down - Worcester Business Journal

What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister

Harvard Bioscience appoints new board member By Investing.com - Investing.com India

Harvard Bioscience Approves Incentive Plan Amendment - TipRanks

Harvard Bioscience appoints new board member - Investing.com

Harvard Bioscience Appoints John Duke to Board of Directors | HB - GuruFocus

Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times

Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan

Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st

Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance

Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN

Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus

Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus

Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey

Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations - GuruFocus

Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa

Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire

Harvard Bioscience: Q1 Earnings Snapshot - MySA

Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financ - GuruFocus

Harvard Bioscience Q1 2025 Earnings Call Transcript - MarketBeat

Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada

HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus

Harvard Bioscience earnings matched, revenue topped estimates - Investing.com

Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha

Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada

Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com

Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus

Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceeding Estimates; Faces Net Loss Due to Goodwill Impairment - GuruFocus

Harvard Bioscience Q1 Net Income USD -50.34 Million - marketscreener.com

Harvard Bioscience Announces First Quarter 2025 Financial Results | HBIO Stock News - GuruFocus

Harvard Bioscience : Q1 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com

Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: W - GuruFocus

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HBIO